{"transactions":[{"id":2846578,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-19T21:35:30.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 18, 2021."}],"balance_after":400000,"derivative":{"exercise_price":1.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-21-004421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315221004421/ownership.xml","form_type":"4"}},{"id":3147502,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Series 1 Common Stock Warrants (right to buy)","published_at":"2020-05-15T20:30:50.000Z","date":"2020-05-14","kind":"other","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the expiration of an unexercised outstanding Warrant in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":0.75,"exercise_date":"2019-03-25","expiration_date":"2020-05-14","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001493152-20-009138","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220009138/ownership.xml","form_type":"4"}},{"id":3284806,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-07T21:11:05.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents a retention grant of award of options to purchase shares of the Company's common stock under the Company's Plan that vest evenly in three tranches.\nOne third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final\nthird vest t on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a retention grant of award of options to purchase shares of the Company's common stock under the Company's Plan that vest evenly in three tranches.\nOne third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final\nthird vest t on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a retention grant of award of options to purchase shares of the Company's common stock under the Company's Plan that vest evenly in three tranches.\nOne third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final\nthird vest t on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents a retention grant of award of options to purchase shares of the Company's common stock under the Company's Plan that vest evenly in three tranches.\nOne third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final\nthird vest t on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020."}],"balance_after":400000,"derivative":{"exercise_price":0.48,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-20-001774","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220001774/ownership.xml","form_type":"4"}},{"id":3284805,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-07T21:11:05.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an annual grant of award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended\n(the \"Plan\") that vests immediately."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended\n(the \"Plan\") that vests immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual grant of award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended\n(the \"Plan\") that vests immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an annual grant of award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended\n(the \"Plan\") that vests immediately."}],"balance_after":400000,"derivative":{"exercise_price":0.48,"exercise_date":"2020-02-05","expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001493152-20-001774","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315220001774/ownership.xml","form_type":"4"}},{"id":3576697,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series 2 Common Stock Warrants (right to buy)","published_at":"2019-03-27T20:05:54.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."}],"balance_after":50000,"derivative":{"exercise_price":0.9,"exercise_date":"2019-03-25","expiration_date":"2024-03-25","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000899243-19-009015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924319009015/doc4.xml","form_type":"4"}},{"id":3576696,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series 1 Common Stock Warrants (right to buy)","published_at":"2019-03-27T20:05:54.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."}],"balance_after":50000,"derivative":{"exercise_price":0.75,"exercise_date":"2019-03-25","expiration_date":"2020-09-25","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000899243-19-009015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924319009015/doc4.xml","form_type":"4"}},{"id":3576695,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-27T20:05:54.000Z","date":"2019-03-25","kind":"purchase","acquired":true,"shares":66667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase of Units consisting of one share of common stock and Series 1 Warrant to purchase one-half of a share of our Common Stock (exercisable through the earlier of 20 days post read out of AG013 clinical trial data or eighteen months) and a Series 2 Warrant to purchase one-half of a share of our Common Stock in an underwritten public offering at the price of $0.75 per Unit, which was the price paid by the public for such Units."}],"balance_after":66667,"source":{"system":"sec-edgar","filing":"0000899243-19-009015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924319009015/doc4.xml","form_type":"4"}},{"id":3804445,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-01T20:05:44.000Z","date":"2018-09-27","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches.  One third of the options vest immediately, the second third of the options vest on the first anniversary of the grant date and the final third vest on the second anniversary of the grant date.  The option exercise price is the closing price on the date of the grant, September 27, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches.  One third of the options vest immediately, the second third of the options vest on the first anniversary of the grant date and the final third vest on the second anniversary of the grant date.  The option exercise price is the closing price on the date of the grant, September 27, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches.  One third of the options vest immediately, the second third of the options vest on the first anniversary of the grant date and the final third vest on the second anniversary of the grant date.  The option exercise price is the closing price on the date of the grant, September 27, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended that vest evenly in three tranches.  One third of the options vest immediately, the second third of the options vest on the first anniversary of the grant date and the final third vest on the second anniversary of the grant date.  The option exercise price is the closing price on the date of the grant, September 27, 2018."}],"balance_after":400000,"derivative":{"exercise_price":0.73,"exercise_date":"2018-09-27","expiration_date":"2028-09-27","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-18-025657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924318025657/doc4.xml","form_type":"4"}},{"id":3883249,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-26T20:24:18.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest on the first anniversary of the grant date.   The option exercise price is the closing price on the date of the grant, June 22, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest on the first anniversary of the grant date.   The option exercise price is the closing price on the date of the grant, June 22, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest on the first anniversary of the grant date.   The option exercise price is the closing price on the date of the grant, June 22, 2018."}],"balance_after":28000,"derivative":{"exercise_price":1.52,"exercise_date":"2019-06-22","expiration_date":"2028-06-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000899243-18-018140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924318018140/doc4.xml","form_type":"4"}},{"id":3888391,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-06-19T16:30:54.000Z","date":"2018-06-16","kind":"grant","acquired":true,"shares":114750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of stock options to each outside independent board member of the issuer."}],"balance_after":436770,"derivative":{"exercise_price":1.8,"exercise_date":"2019-06-16","expiration_date":"2028-06-16","underlying":"Common Stock","underlying_shares":114750},"source":{"system":"sec-edgar","filing":"0001104659-18-041062","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294887/000110465918041062/a4.xml","form_type":"4"}},{"id":4269106,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T17:08:37.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":321520,"derivative":{"exercise_price":1.4,"exercise_date":"2017-06-28","expiration_date":"2019-11-20","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001104659-17-043011","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1294887/000110465917043011/a4.xml","form_type":"4"}},{"id":4269105,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T17:08:37.000Z","date":"2017-06-28","kind":"disposition_to_issuer","acquired":false,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions with this same footnote involved an amendment of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The old option was originally granted on November 20, 2009. The vesting schedule of the old option was reported on a Form 3 filed by the reporting person on August 3, 2011."}],"balance_after":295020,"derivative":{"exercise_price":1.4,"expiration_date":"2019-11-20","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0001104659-17-043011","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1294887/000110465917043011/a4.xml","form_type":"4"}},{"id":4269104,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T17:08:37.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":321520,"derivative":{"exercise_price":4.5,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001104659-17-043011","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1294887/000110465917043011/a4.xml","form_type":"4"}},{"id":4272628,"issuer":{"id":8495,"kind":"organization","name":"ORAGENICS INC"},"owners":[{"id":142438,"kind":"person","name":"Joslyn Alan","position":1,"cik":"0001294887","reported_name":"Joslyn Alan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Director Option (Right to Buy)","published_at":"2017-06-26T19:27:43.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest equally over three years commencing on the first anniversary of the grant date.   The option exercise price is the closing price on the date of the grant, June 22, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest equally over three years commencing on the first anniversary of the grant date.   The option exercise price is the closing price on the date of the grant, June 22, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, that vest equally over three years commencing on the first anniversary of the grant date.   The option exercise price is the closing price on the date of the grant, June 22, 2017."}],"balance_after":140000,"derivative":{"exercise_price":0.37,"exercise_date":"2017-06-22","expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000899243-17-017197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1174940/000089924317017197/doc4.xml","form_type":"4"}}]}